Remove BioTech Remove Data Remove Drug Development Remove Health Information
article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. This hasn’t been made clear yet due in part to the fourth and final guidance session on clinical outcome assessment data yet to occur in 2023.

BioTech 145
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

For the pharmacovigilance space, for example, this automation will begin as a tool for recommendations, suggestions or options for potential safety reports, but it will not fully replace human efforts particularly as there are concerns around data output consistency. Dave Latshaw, CEO at BioPhy 1.

Health IT 110